Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $74 | $88 | $121 | $124 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $144 | $126 | $0 | $0 |
| Inventory | $217 | $224 | $176 | $149 |
| Other Curr. Assets | $32 | $22 | $148 | $103 |
| Total Curr. Assets | $468 | $459 | $444 | $376 |
| Property Plant & Equip (Net) | $159 | $155 | $100 | $92 |
| Goodwill | $335 | $0 | $245 | $0 |
| Intangibles | $588 | $1,111 | $485 | $689 |
| Long-Term Investments | $15 | $15 | $16 | $18 |
| Tax Assets | $5 | $3 | $2 | $2 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,102 | $1,285 | $849 | $802 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,569 | $1,744 | $1,293 | $1,178 |
| Liabilities | – | – | – | – |
| Payables | $43 | $139 | $46 | $100 |
| Short-Term Debt | $4 | $3 | $3 | $3 |
| Tax Payable | $12 | $22 | $12 | $19 |
| Deferred Revenue | $12 | $22 | $12 | $19 |
| Other Curr. Liab. | -$7 | -$18 | -$6 | -$12 |
| Total Curr. Liab. | $164 | $168 | $159 | $129 |
| LT Debt | $501 | $508 | $326 | $312 |
| Deferred Rev, NC | $2 | $2 | $2 | $2 |
| Deferred Tax Liab, NC | $76 | $125 | $36 | $43 |
| Other NC Liab. | $72 | $99 | $104 | $50 |
| Total NC Liab. | $650 | $734 | $468 | $409 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | -$2 |
| Total Liabilities | $814 | $903 | $627 | $539 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $87 | $151 | $164 | $158 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | -$88 | -$152 | -$165 | -$159 |
| Total Equity | $755 | $842 | $667 | $639 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,569 | $1,744 | $1,293 | $1,178 |
| Net Debt | $430 | $423 | $208 | $191 |